iRobot Co. (NASDAQ:IRBT) Expected to Post Quarterly Sales of $267.90 Million

Analysts expect iRobot Co. (NASDAQ:IRBT) to announce $267.90 million in sales for the current fiscal quarter, according to Zacks Investment Research. Four analysts have provided estimates for iRobot’s earnings, with estimates ranging from $265.95 million to $268.80 million. iRobot reported sales of $226.32 million during the same quarter last year, which indicates a positive year over year growth rate of 18.4%. The firm is scheduled to issue its next quarterly earnings results after the market closes on Tuesday, July 23rd.

According to Zacks, analysts expect that iRobot will report full-year sales of $1.29 billion for the current financial year, with estimates ranging from $1.27 billion to $1.30 billion. For the next fiscal year, analysts forecast that the business will report sales of $1.47 billion, with estimates ranging from $1.42 billion to $1.52 billion. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research firms that follow iRobot.

iRobot (NASDAQ:IRBT) last posted its quarterly earnings data on Tuesday, April 23rd. The industrial products company reported $0.84 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.68 by $0.16. iRobot had a net margin of 8.09% and a return on equity of 17.64%. The company had revenue of $237.66 million during the quarter, compared to analysts’ expectations of $251.40 million. During the same period in the prior year, the business posted $0.71 earnings per share. The firm’s revenue for the quarter was up 9.5% on a year-over-year basis.

A number of brokerages recently issued reports on IRBT. JPMorgan Chase & Co. set a €8.75 ($10.17) price objective on shares of Commerzbank and gave the company a “buy” rating in a report on Thursday, April 18th. Northland Securities reissued a “buy” rating and issued a $130.00 price objective on shares of iRobot in a report on Wednesday. Citigroup set a $95.00 price objective on shares of iRobot and gave the company a “hold” rating in a report on Wednesday, July 3rd. ValuEngine lowered shares of Zosano Pharma from a “buy” rating to a “hold” rating in a report on Wednesday, May 1st. Finally, Zacks Investment Research lowered shares of Hancock Jaffe Laboratories from a “buy” rating to a “hold” rating in a report on Wednesday, June 26th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating, one has assigned a buy rating and one has given a strong buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $109.36.

Shares of iRobot stock traded down $1.88 during trading hours on Monday, reaching $91.70. 18,706 shares of the company’s stock were exchanged, compared to its average volume of 500,642. iRobot has a 1 year low of $70.86 and a 1 year high of $132.88. The stock has a market capitalization of $2.57 billion, a P/E ratio of 21.13, a P/E/G ratio of 1.43 and a beta of 1.61. The firm has a fifty day moving average price of $90.20. The company has a debt-to-equity ratio of 0.11, a current ratio of 3.22 and a quick ratio of 1.97.

In other iRobot news, CEO Colin M. Angle sold 11,486 shares of the stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $87.07, for a total transaction of $1,000,086.02. Following the completion of the transaction, the chief executive officer now owns 402,368 shares of the company’s stock, valued at $35,034,181.76. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Andrew Miller sold 878 shares of the stock in a transaction dated Monday, June 10th. The stock was sold at an average price of $91.97, for a total transaction of $80,749.66. Following the transaction, the director now directly owns 14,199 shares of the company’s stock, valued at approximately $1,305,882.03. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 23,693 shares of company stock valued at $2,156,268. 3.01% of the stock is currently owned by insiders.

A number of hedge funds have recently made changes to their positions in IRBT. Osborn Williams & Donohoe LLC purchased a new position in iRobot during the first quarter worth about $29,000. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA lifted its position in shares of iRobot by 16.7% during the first quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 700 shares of the industrial products company’s stock worth $82,000 after purchasing an additional 100 shares in the last quarter. American Research & Management Co. acquired a new stake in shares of iRobot during the first quarter worth about $118,000. Lakeview Capital Partners LLC acquired a new stake in shares of iRobot during the first quarter worth about $202,000. Finally, First Republic Investment Management Inc. acquired a new stake in shares of iRobot during the first quarter worth about $223,000. 97.16% of the stock is owned by institutional investors.

iRobot Company Profile

iRobot Corporation designs, builds, and sells robots for the consumer market worldwide. It offers Roomba floor vacuuming robots; Braava family of automatic floor mopping robots; and Mirra Pool Cleaning Robot to clean residential pools and removes debris as small as two microns from pool floors, walls, and stairs.

Further Reading: Technical Analysis of Stocks and What It Means

Get a free copy of the Zacks research report on iRobot (IRBT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for iRobot (NASDAQ:IRBT)

Receive News & Ratings for iRobot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iRobot and related companies with MarketBeat.com's FREE daily email newsletter.